DrugPatentWatch Database Preview

Deutetrabenazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for deutetrabenazine and what is the scope of freedom to operate?

Deutetrabenazine is the generic ingredient in one branded drug marketed by Teva Branded Pharm and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Deutetrabenazine has forty-seven patent family members in twenty countries.

One supplier is listed for this compound.

Summary for deutetrabenazine

International Patents:	47
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	15
Clinical Trials:	12
Patent Applications:	9
Formulation / Manufacturing:	see details
DailyMed Link:	deutetrabenazine at DailyMed

Recent Clinical Trials for deutetrabenazine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Teva Branded Pharmaceutical Products, R&D Inc.	Phase 1/Phase 2
University of Pennsylvania	Phase 1/Phase 2
Teva Branded Pharmaceutical Products, R&D Inc.	Phase 3

See all deutetrabenazine clinical trials

Synonyms for deutetrabenazine

(+)-Tetrabenazine D6

(3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one

(3RS,11Brs)-9,10-di((2H3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-one

[2H6]-(+)-Tetrabenazine|||[2H6]-(+)- 9,10-Dimethoxy-1,3R,4,6,7,11bR-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one

1392826-25-3

1977511-05-9

2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3R,11bR)-rel-

Austedo

Austedo (TN)

CHEMBL3137326

D10701

DB12161

Deutetrabenazine (USAN/INN)

Deutetrabenazine [USAN:INN]

Dutetrabenazine

GTPL8707

HY-B0590S

Q27077026

Ro 1-9569 D6

SCHEMBL13321841

SCHEMBL16227993

SCHEMBL16228022

SD 809

SD-809

SD809

Tetrabenazine D6

Tetrabenazine-d6

UNII-P341G6W9NB component MKJIEFSOBYUXJB-VFJJUKLQSA-N

UNII-P341G6W9NB component MKJIEFSOBYUXJB-WEZHFFAMSA-N

US Patents and Regulatory Information for deutetrabenazine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No			Y	Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-003	Apr 3, 2017		RX	Yes	Yes			Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No			Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-003	Apr 3, 2017		RX	Yes	Yes
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No			Y	Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No			Y

International Patents for deutetrabenazine

Country	Patent Number	Estimated Expiration
Denmark	2326643
Canada	2883641
World Intellectual Property Organization (WIPO)	2014047167
Spain	2425623
European Patent Office	2326643
Croatia	P20180239
Poland	3061760